From the SDSU Heart Institute, Department of Biology (N.A.G., F.F., K.M.B., K.I., K.P.N., C.R.P., V.S., M.M.M., A.R.C., F.G.K., B.J.W., D.E.E., R.A., M.A.S.).
San Diego State University, CA; Sharp Memorial Hospital, San Diego, CA (W.P.D.).
Circ Res. 2018 Jun 22;123(1):57-72. doi: 10.1161/CIRCRESAHA.117.311828. Epub 2018 Apr 10.
Biological significance of c-Kit as a cardiac stem cell marker and role(s) of c-Kit+ cells in myocardial development or response to pathological injury remain unresolved because of varied and discrepant findings. Alternative experimental models are required to contextualize and reconcile discordant published observations of cardiac c-Kit myocardial biology and provide meaningful insights regarding clinical relevance of c-Kit signaling for translational cell therapy.
The main objectives of this study are as follows: demonstrating c-Kit myocardial biology through combined studies of both human and murine cardiac cells; advancing understanding of c-Kit myocardial biology through creation and characterization of a novel, inducible transgenic c-Kit reporter mouse model that overcomes limitations inherent to knock-in reporter models; and providing perspective to reconcile disparate viewpoints on c-Kit biology in the myocardium.
In vitro studies confirm a critical role for c-Kit signaling in both cardiomyocytes and cardiac stem cells. Activation of c-Kit receptor promotes cell survival and proliferation in stem cells and cardiomyocytes of either human or murine origin. For creation of the mouse model, the cloned mouse c-Kit promoter drives Histone2B-EGFP (enhanced green fluorescent protein; H2BEGFP) expression in a doxycycline-inducible transgenic reporter line. The combination of c-Kit transgenesis coupled to H2BEGFP readout provides sensitive, specific, inducible, and persistent tracking of c-Kit promoter activation. Tagging efficiency for EGFP+/c-Kit+ cells is similar between our transgenic versus a c-Kit knock-in mouse line, but frequency of c-Kit+ cells in cardiac tissue from the knock-in model is 55% lower than that from our transgenic line. The c-Kit transgenic reporter model reveals intimate association of c-Kit expression with adult myocardial biology. Both cardiac stem cells and a subpopulation of cardiomyocytes express c-Kit in uninjured adult heart, upregulating c-Kit expression in response to pathological stress.
c-Kit myocardial biology is more complex and varied than previously appreciated or documented, demonstrating validity in multiple points of coexisting yet heretofore seemingly irreconcilable published findings.
由于各种相互矛盾的发现,c-Kit 作为心脏干细胞标志物的生物学意义以及 c-Kit+细胞在心肌发育或对病理性损伤的反应中的作用仍未得到解决。需要替代的实验模型来使发表的关于心脏 c-Kit 心肌生物学的不一致观察结果背景化和协调,并为 c-Kit 信号对转化细胞治疗的临床相关性提供有意义的见解。
本研究的主要目的如下:通过对人和鼠心脏细胞的联合研究来证明 c-Kit 的心肌生物学;通过创建和表征一种新型的、可诱导的转基因 c-Kit 报告小鼠模型来推进对 c-Kit 心肌生物学的理解,该模型克服了敲入报告模型固有的局限性;并为协调对心肌中 c-Kit 生物学的不同观点提供视角。
体外研究证实 c-Kit 信号在心肌细胞和心脏干细胞中都起着关键作用。c-Kit 受体的激活促进了人类或鼠来源的干细胞和心肌细胞的存活和增殖。为了创建小鼠模型,克隆的小鼠 c-Kit 启动子驱动 Histone2B-EGFP(增强型绿色荧光蛋白;H2BEGFP)在一种强力霉素诱导的转基因报告线中表达。c-Kit 转基因与 H2BEGFP 读出相结合,提供了对 c-Kit 启动子激活的敏感、特异、诱导和持久的追踪。与我们的转基因小鼠相比,EGFP+/c-Kit+细胞的标记效率相似,但在心脏组织中 c-Kit+细胞的频率从敲入模型比我们的转基因线低 55%。c-Kit 转基因报告小鼠模型揭示了 c-Kit 表达与成年心肌生物学的密切关联。在未受伤的成年心脏中,心脏干细胞和心肌细胞的亚群都表达 c-Kit,并在病理性应激下上调 c-Kit 表达。
c-Kit 的心肌生物学比以前认为或记录的更复杂和多样化,在多个共存但迄今为止似乎无法协调的已发表发现中证明了其有效性。